Home kit boosts emotional bond between parents and unborn baby

NCT ID NCT07692100

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a program called the Maternal-Fetal Attachment Kit (MaKit) designed to help pregnant women and their partners feel more emotionally connected to their unborn baby. Thirty couples attending antenatal care in Indonesia are split into two groups: one receives standard care plus MaKit, the other standard care only. MaKit provides structured home activities for both parents to nurture bonding. The goal is to see if this simple, couple-focused approach can improve emotional attachment during pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Maternal-Fetal Attachment Kit (MaKit) – a home-based psychosocial intervention with structured activities for expectant couples
What this could lead to
If effective, MaKit could offer a simple, low-cost way for clinics to help parents bond emotionally with their baby during pregnancy, improving well-being and readiness for parenthood.
What could go wrong
This is a small, early study with only 30 couples at one clinic in Indonesia. Larger, more diverse trials are needed to confirm the benefits and see if they last after birth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Mar 2025

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * pregnant women 16-36 weeks' gestation with a singleton pregnancy, i * in marital union, * attending the antenatal care visit with their husband, * willing partner to participate in the intervention, and * able to communicate in Indonesian Exclusion Criteria: * women ≥37 weeks' gestation (as they would likely deliver before completing the four-week intervention and follow-up).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attachment are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Klinik Aisyiyah Moyudan

    Sleman, Special Region of Yogyakarta, 55292, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.